Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-60
SponsorUniversity of Faisalabad

About this trial

Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.

Eligibility criteria

Qualifiers

Unilateral hemiplegia secondary to stroke

Age between 30 and 60 years

Subacute stage (3 to 6 months post-stroke)

Fugl-Meyer Assessment (FMA) score between 20 and 50

Disqualifiers

Previous peripheral nerve injury or surgery affecting the upper limb

Fixed contractures or bony fractures in the affected limb

Complete sensory loss of the upper limb

Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia)

Trial design

Treatments tested in this trial

  • Wearable Focal Muscle Vibrator

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

The University of FaisalabadRecruiting3800, Faisalābad, Punjab ProvincePakistanPakistan

Sponsors and collaborators